Status:
COMPLETED
Penicillin and Metronidazole in Treatment of Peritonsillar Abscess
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Peritonsillar Abscess
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment of peritonsillar abscess varies. To study whether broad spectrum antibiotics are required in addition to abscess drainage, a prospective, double blind, placebo-controlled, randomized study o...
Eligibility Criteria
Inclusion
- referring doctor suspects peritonsillar abscess
- patient is voluntary
- patient has daily access to his/her e-mail
- patient speaks and understands Finnish of Swedish
- female patients have adequate birth-control method
- patient has peritonsillar abscess
Exclusion
- allergy to penicillin
- allergy to metronidazole
- use of metronidazole in preceding one month
- pregnancy
- breast-feeding
- renal insufficiency
- liver insufficiency
- alcoholism (drunk at least once a week)
- participant in another clinical trial at the moment
- treatment of peritonsillar abscess requires in-patient care
- tonsillectomy during the next 30 days
- army recruit
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01255670
Start Date
February 1 2010
End Date
April 1 2011
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Central Hospital
Helsinki, Finland, 00029